NO20074880L - Proteaseinhibitor forloper syntese - Google Patents

Proteaseinhibitor forloper syntese

Info

Publication number
NO20074880L
NO20074880L NO20074880A NO20074880A NO20074880L NO 20074880 L NO20074880 L NO 20074880L NO 20074880 A NO20074880 A NO 20074880A NO 20074880 A NO20074880 A NO 20074880A NO 20074880 L NO20074880 L NO 20074880L
Authority
NO
Norway
Prior art keywords
synthesis
protease inhibitor
proceeds
inhibitor proceeds
processes
Prior art date
Application number
NO20074880A
Other languages
English (en)
Norwegian (no)
Inventor
Bruno Linclau
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of NO20074880L publication Critical patent/NO20074880L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
NO20074880A 2005-02-25 2007-09-25 Proteaseinhibitor forloper syntese NO20074880L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05101462 2005-02-25
US68369905P 2005-05-23 2005-05-23
PCT/EP2006/060246 WO2006089942A1 (fr) 2005-02-25 2006-02-24 Synthese de precurseur d'inhibiteur de la protease

Publications (1)

Publication Number Publication Date
NO20074880L true NO20074880L (no) 2007-09-25

Family

ID=36646227

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074880A NO20074880L (no) 2005-02-25 2007-09-25 Proteaseinhibitor forloper syntese

Country Status (19)

Country Link
US (2) US8067463B2 (fr)
EP (1) EP1856125B1 (fr)
JP (1) JP5260965B2 (fr)
KR (1) KR101333627B1 (fr)
CN (1) CN101128469B (fr)
AT (1) ATE440848T1 (fr)
AU (1) AU2006217922B2 (fr)
BR (1) BRPI0607827B8 (fr)
CA (1) CA2595295C (fr)
DE (1) DE602006008751D1 (fr)
DK (1) DK1856125T3 (fr)
ES (1) ES2331257T3 (fr)
IL (1) IL184519A (fr)
MX (1) MX2007010378A (fr)
NO (1) NO20074880L (fr)
PL (1) PL1856125T3 (fr)
PT (1) PT1856125E (fr)
RU (1) RU2421459C2 (fr)
WO (1) WO2006089942A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5288153B2 (ja) * 2007-03-30 2013-09-11 日油株式会社 糖アルコール誘導体およびアルケニル基含有糖アルコール誘導体の製造方法
US8802724B2 (en) * 2010-11-30 2014-08-12 Purdue Research Foundation Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE500823T1 (de) 1998-06-23 2011-03-15 Us Of America Represented By The Secretary Dept Of Health And Human Services Arzneimittel zur behandlung von hiv-infizierten säugetieren
WO1999067254A2 (fr) 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Inhibiteurs de protease retrovirale resistant a l'action de plusieurs medicaments et procedes associes
EP1089328A1 (fr) 1999-09-29 2001-04-04 Infineon Technologies AG Méthode de formation d'un dispositif semiconducteur
AP1459A (en) 1999-10-06 2005-08-22 Tibotec Pharm Ltd Hexahydrofuro [2,3-b] furan-3- YL-N-{3-[(1,3- benzodioxol-5- ylsufonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor.
CA2438304C (fr) 2001-02-14 2011-04-12 Dominique Louis Nestor Ghislain Surleraux Sulfamides de 2-amino-benzothiazole substitue en tant qu'inhibiteurs de la protease du vih a large spectre
HUP0303744A3 (en) 2001-04-09 2008-03-28 Tibotec Pharm Ltd Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors and pharmaceutical compositions containing them
PL209029B1 (pl) 2001-05-11 2011-07-29 Tibotec Pharm Ltd Pochodne 2-aminobenzoksazolo-sulfonamidów jako inhibitory proteazy HIV, oraz kompozycje zawierające te związki
US7087373B2 (en) 2001-06-05 2006-08-08 Tibotec Pharmaceuticals Ltd. Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins
TWI286476B (en) 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
PL216539B1 (pl) 2001-12-21 2014-04-30 Tibotec Pharm Ltd Związki fenylosulfonylowe i zastosowanie związków fenylosulfonylowych
EP1483254A4 (fr) 2002-01-07 2005-06-08 Sequoia Pharmaceuticals Inhibiteurs de protease retrovirale anti-resistance
CA2474671A1 (fr) 2002-02-22 2003-08-28 Tibotec Bvba Procedes de determination de l'influence du plasma ou la liaison de proteines seriques humains sur l'activite antiretrovirale
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
TWI332956B (en) 2002-04-26 2010-11-11 Gilead Sciences Inc Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
SI1567529T2 (sl) 2002-05-16 2021-08-31 Janssen Sciences Ireland Unlimited Company Psevdopolimorfne oblike zaviralca HIV proteaze
DK1517899T3 (da) 2002-05-17 2007-12-03 Tibotec Pharm Ltd Bredspektret substitueret benzisoxazolsulfonamid HIV-proteaseinhibitor
US7217506B2 (en) 2002-07-01 2007-05-15 Tibotec Pharmaceuticals, Ltd. Mutational profiles in HIV-1 protease correlated with phenotypic protease inhibitor resistance

Also Published As

Publication number Publication date
BRPI0607827A2 (pt) 2009-10-06
EP1856125A1 (fr) 2007-11-21
ES2331257T3 (es) 2009-12-28
PL1856125T3 (pl) 2010-01-29
JP5260965B2 (ja) 2013-08-14
CN101128469B (zh) 2012-11-14
IL184519A (en) 2012-01-31
US8183394B2 (en) 2012-05-22
AU2006217922A1 (en) 2006-08-31
KR101333627B1 (ko) 2013-11-27
PT1856125E (pt) 2009-11-06
MX2007010378A (es) 2007-09-25
EP1856125B1 (fr) 2009-08-26
IL184519A0 (en) 2007-10-31
US20120041215A1 (en) 2012-02-16
CA2595295C (fr) 2014-07-08
BRPI0607827B8 (pt) 2021-05-25
WO2006089942A8 (fr) 2007-12-13
KR20080005183A (ko) 2008-01-10
US20090054668A1 (en) 2009-02-26
BRPI0607827B1 (pt) 2019-11-05
RU2007135345A (ru) 2009-03-27
ATE440848T1 (de) 2009-09-15
DE602006008751D1 (de) 2009-10-08
US8067463B2 (en) 2011-11-29
JP2008531522A (ja) 2008-08-14
WO2006089942A1 (fr) 2006-08-31
RU2421459C2 (ru) 2011-06-20
AU2006217922B2 (en) 2012-04-05
DK1856125T3 (da) 2009-12-07
CA2595295A1 (fr) 2006-08-31
CN101128469A (zh) 2008-02-20

Similar Documents

Publication Publication Date Title
MX2007003118A (es) Procedimiento de intermediarios para preparar inhibidores de cisteina proteasa.
CR7680A (es) Un nuevo proceso para la sintesis de agomelatina
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
DE602007012559D1 (de) H die schleimhaut
ITMI20050801A1 (it) Procedimento per la preparazione di telmisartan
DE602007004086D1 (de) Acrylierte hyaluronsäure
EA200500202A1 (ru) Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина
UA102220C2 (ru) Способ синтеза агомелатина
UA97806C2 (ru) Бензиламины, способ их получения и их применения в качестве противовоспалительных средств
MX2012003488A (es) Proceso para la elaboracion de n-acil-bifenil-alanina.
ATE429417T1 (de) Hiv-protease-inhibitoren
EA200500204A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
IL189286A0 (en) Novel cysteine protease inhibitors and their therapeutic applications
SG158860A1 (en) Processes for the preparation of aminoethoxybenzyl alcohols
MX2007013872A (es) Procedimiento para la produccion de 4-bifenililazetidina-2-onas.
NO20074880L (no) Proteaseinhibitor forloper syntese
BRPI0607390A2 (pt) Processo para recuperar cci-779 de licores mâe
TW200728267A (en) Processes and intermediates for the preparation of prostaglandins
ITMI20060488A1 (it) Procedimento per la preparazione di 3,4-bis trifluoronetil-n-metilbenzilammina
UA94391C2 (ru) Синтез предшественника ингибитора протеазы
EA200802065A1 (ru) Синтез замещённых флуоренов
TW200740366A (en) Novel fluorescent cichlid and method for producing thereof
ATE464280T1 (de) Synthese von idarubin-aglycon

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: JANSSEN SCIENCES IRELAND UC, IE

FC2A Withdrawal, rejection or dismissal of laid open patent application